Diagnostic Imaging for Clear Cell Renal Cell Carcinoma

NCT03185182 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Due to "early stopping rule" as defined in the study protocol

Conditions

Clear Cell Renal Cell Carcinoma

Interventions

DRUG: Ioflupane I123

Sponsor

Region Skane

Collaborators

[object Object]